|
|
.
|
Professional Consulting: Key Areas
| What to Do |
How to Do It |
Key Issues |
|
|
|
| I. Strategy Setting |
|
|
| - Overall |
Brainstorming |
Avoiding problems |
| - Clinical |
Telecons |
Fastest route to goals |
| - Regulatory |
Written proposals |
Regulatory acceptability |
|
|
|
| II. Planning |
|
|
| -What to do |
Meetings |
What can be eliminated |
| -When to do it |
Proposals |
What can be delayed |
| -Who to do it |
Periodic reviews |
Regulatory acceptability |
| -How much to do it |
Due diligence |
Can costs be cut |
|
|
|
| III. Implementing Plans |
|
|
| -Keeping on track |
Weekly project meetings |
Identify potential issues/problems |
| -Preventing tangents |
Ad hoc meetings |
Should activities be simultaneous or sequential |
| -Solving problems |
Monitoring progress versus plans |
|
|
|
|
| IV. Preparing Documents |
|
|
| -White papers |
Prepare a synopsis first |
Other issues to address |
| -Final study reports |
Develop shells/templates |
How can we support our position |
| -Regulatory submissions |
Create boilerplate |
|
| -Clinical protocols |
|
|
|
|
|
| V. Review Documents |
|
|
| -Are key messages included |
Content experts |
Are issues/problems transparent |
| -Is the discussion complete |
Method experts |
Is the interpretation complete |
| -Is the structure sound |
|
Is the report logical |
| -Is the organization logical |
|
Is the report supported by evidence |
| -Is anything missing |
|
|
|
|
|
| VI. Miscellaneous |
|
Shorten drug development
| Review documents, interview staff and make recommendations | |
| Raise money |
Contact my financial associates and others |
| Locate other experts |
Contact my extensive network of independent Consultants |
Copyright © 2002-2008 Bert Spilker & Associates, LLC. All rights reserved.
|